New TB vaccines enter human safety trials
NCT ID NCT05537038
First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This early-stage trial tested two experimental vaccines against tuberculosis in 120 healthy adults who had never received a TB vaccine or been exposed to TB. The main goal was to check safety and find the best dose. Participants received three shots of either a vaccine or a placebo and were monitored for side effects and immune responses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Berlin GmbH
Berlin, 13627, Germany
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
-
emovis GmbH
Berlin, 10629, Germany
Conditions
Explore the condition pages connected to this study.